iShares Genomics Immunology and Healthcare ETF IDNA
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.47%
- Net assets
- $190.9M
- Holdings
- 61
- 12-month distribution yield
- 0.67%
- Asset class
- Equity
iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund listed on NYSE Arca in the United States, issued by iShares. Its category is Equity · Global (equity). Its last price was US$42.05 on 20 Oct 2026. Its expense ratio is 0.47% a year, from its prospectus dated 28 Nov 2025. It reported net assets of US$190.86 million as of 31 Jul 2026. Its latest holdings report lists 61 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.28 a unit, a 12-month distribution yield of 0.67%, paid twice a year.
Fees
- Total annual operating expenses (gross)
- 0.47%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.47%
- Prospectus date
- 28 Nov 2025
- Filed with the SEC
- 21 Nov 2025
Size and reporting
- Net assets
- $190,862,668
- Total assets
- $210,785,506
- Holdings as of
- 31 Jul 2026
- Report made public
- 23 Sep 2026 (54 days after the month end)
Top holdings
Largest 25 of 61 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | US0669225197 | 10.39% | $19.8M | Short-term investment vehicles (cash funds) | United States | USD |
| 2 | Bayer Aktiengesellschaft BAYER AG | DE000BAY0017 | 4.81% | $9.2M | Equity (common) | Germany | EUR |
| 3 | Twist Bioscience Corp | US90184D1000 | 4.79% | $9.1M | Equity (common) | United States | USD |
| 4 | REVOLUTION MEDICINES, INC. | US76155X1000 | 4.55% | $8.7M | Equity (common) | United States | USD |
| 5 | REGENERON PHARMACEUTICALS, INC. | US75886F1075 | 4.35% | $8.3M | Equity (common) | United States | USD |
| 6 | GENMAB A/S | DK0010272202 | 4.23% | $8.1M | Equity (common) | Denmark | DKK |
| 7 | INCYTE CORPORATION | US45337C1027 | 4.23% | $8.1M | Equity (common) | United States | USD |
| 8 | MODERNA, INC. | US60770K1079 | 4.19% | $8.0M | Equity (common) | United States | USD |
| 9 | Takeda Pharmaceutical Company Limited TAKEDA PHARMACEUTICAL CO LTD | JP3463000004 | 4.05% | $7.7M | Equity (common) | Japan | JPY |
| 10 | MERCK & CO., INC. | US58933Y1055 | 3.91% | $7.5M | Equity (common) | United States | USD |
| 11 | VERTEX PHARMACEUTICALS INCORPORATED | US92532F1003 | 3.87% | $7.4M | Equity (common) | United States | USD |
| 12 | Roche Holding AG | CH1499059983 | 3.85% | $7.3M | Equity (common) | Switzerland | CHF |
| 13 | IPSEN SA | FR0010259150 | 3.84% | $7.3M | Equity (common) | France | EUR |
| 14 | BioNTech SE | US09075V1026 | 3.73% | $7.1M | Other | Germany | USD |
| 15 | EXELIXIS, INC. | US30161Q1040 | 3.65% | $7.0M | Equity (common) | United States | USD |
| 16 | GSK PLC | GB00BN7SWP63 | 3.63% | $6.9M | Equity (common) | United Kingdom | GBP |
| 17 | SANOFI SA | FR0000120578 | 3.46% | $6.6M | Equity (common) | France | EUR |
| 18 | IDEAYA Biosciences Inc | US45166A1025 | 3.36% | $6.4M | Equity (common) | United States | USD |
| 19 | Immunitybio Inc | US45256X1037 | 3.07% | $5.9M | Equity (common) | United States | USD |
| 20 | ARCUS BIOSCIENCES, INC. | US03969F1093 | 2.68% | $5.1M | Equity (common) | United States | USD |
| 21 | CARIS LIFE SCIENCES, INC. | US1421521071 | 2.18% | $4.2M | Equity (common) | United States | USD |
| 22 | ONO PHARMACEUTICAL CO., LTD. | JP3197600004 | 1.91% | $3.7M | Equity (common) | Japan | JPY |
| 23 | Iovance Biotherapeutics Inc | US4622601007 | 1.80% | $3.4M | Equity (common) | United States | USD |
| 24 | NUVATION BIO INC. | US67080N1019 | 1.78% | $3.4M | Equity (common) | United States | USD |
| 25 | CRISPR Therapeutics AG | CH0334081137 | 1.57% | $3.0M | Equity (common) | Switzerland | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 96.02% | |
| Short-term investment vehicles (cash funds) | 10.49% | |
| Other | 3.81% | |
| Equity derivatives | 0.01% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 70.15% | |
| Germany | 8.54% | |
| France | 7.76% | |
| Japan | 6.00% | |
| Switzerland | 5.41% | |
| Denmark | 4.24% | |
| United Kingdom | 3.66% | |
| China | 2.26% | |
| Canada | 1.52% | |
| Luxembourg | 0.53% | |
| South Korea | 0.25% | |
| Hong Kong | <0.01% | |
| Other (2) | <0.01% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 77.49% | |
| Euro (EUR) | 12.57% | |
| Japanese yen (JPY) | 6.00% | |
| Danish krone (DKK) | 4.24% | |
| Swiss franc (CHF) | 3.85% | |
| British pound (GBP) | 3.66% | |
| Hong Kong dollar (HKD) | 2.27% | |
| South Korean won (KRW) | 0.25% | |
| New Taiwan dollar (TWD) | <0.01% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 39.82% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.2800
- 12-month yield
- 0.67%
- Frequency
- Twice a year
- Latest ex-date
- 15 Jun 2026
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.2800) ÷ latest price ($42.05) × 100 = 0.67%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (9 payments)
| Ex-date | Amount per unit |
|---|---|
| 15 Jun 2026 | $0.1250 |
| 16 Dec 2025 | $0.1550 |
| 16 Jun 2025 | $0.1530 |
| 17 Dec 2024 | $0.1110 |
| 11 Jun 2024 | $0.1110 |
| 20 Dec 2023 | $0.1690 |
| 7 Jun 2023 | $0.0710 |
| 9 Jun 2022 | $0.1360 |
| 13 Dec 2021 | $0.2560 |
Filings and sources
- Form N-PORT report for July 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000065599) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- IDNA and VT Vanguard Total World Stock Index ETF
- IDNA and SMH VanEck Semiconductor ETF
- IDNA and SOXX iShares PHLX SOX Semiconductor Sector Index Fund
- IDNA and CGDV Capital Group Dividend Value ETF